annual CFO:
$97.05M+$47.47M(+95.75%)Summary
- As of today (May 23, 2025), LGND annual cash flow from operations is $97.05 million, with the most recent change of +$47.47 million (+95.75%) on December 31, 2024.
- During the last 3 years, LGND annual CFO has risen by +$18.25 million (+23.16%).
- LGND annual CFO is now -49.99% below its all-time high of $194.06 million, reached on December 31, 2018.
Performance
LGND Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$25.45M-$53.92M(-189.37%)Summary
- As of today (May 23, 2025), LGND quarterly cash flow from operations is -$25.45 million, with the most recent change of -$53.92 million (-189.37%) on March 31, 2025.
- Over the past year, LGND quarterly CFO has dropped by -$44.18 million (-235.84%).
- LGND quarterly CFO is now -134.55% below its all-time high of $73.64 million, reached on June 30, 2018.
Performance
LGND quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
$52.87M-$44.18M(-45.52%)Summary
- As of today (May 23, 2025), LGND TTM cash flow from operations is $52.87 million, with the most recent change of -$44.18 million (-45.52%) on March 31, 2025.
- Over the past year, LGND TTM CFO has increased by +$18.51 million (+53.87%).
- LGND TTM CFO is now -72.76% below its all-time high of $194.06 million, reached on December 31, 2018.
Performance
LGND TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
LGND Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +95.8% | -235.8% | +53.9% |
| 3 y3 years | +23.2% | -148.9% | -56.0% |
| 5 y5 years | +430.8% | -250.4% | +191.7% |
LGND Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -29.6% | +95.8% | -147.6% | at low | -61.6% | +53.9% |
| 5 y | 5-year | -29.6% | +430.8% | -147.6% | at low | -61.6% | +191.7% |
| alltime | all time | -50.0% | +170.1% | -134.6% | +69.7% | -72.8% | +128.3% |
LGND Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$25.45M(-189.4%) | $52.87M(-45.5%) |
| Dec 2024 | $97.05M(+95.8%) | $28.47M(-22.1%) | $97.05M(+26.6%) |
| Sep 2024 | - | $36.53M(+174.4%) | $76.64M(+60.5%) |
| Jun 2024 | - | $13.31M(-28.9%) | $47.76M(+39.0%) |
| Mar 2024 | - | $18.73M(+132.3%) | $34.36M(-30.7%) |
| Dec 2023 | $49.58M(-64.0%) | $8.06M(+5.5%) | $49.58M(-47.8%) |
| Sep 2023 | - | $7.65M(-9424.4%) | $94.98M(-11.9%) |
| Jun 2023 | - | -$82.00K(-100.2%) | $107.83M(-10.0%) |
| Mar 2023 | - | $33.95M(-36.5%) | $119.79M(-13.1%) |
| Dec 2022 | $137.85M(+74.9%) | $53.47M(+161.0%) | $137.85M(+23.1%) |
| Sep 2022 | - | $20.49M(+72.5%) | $112.02M(+0.4%) |
| Jun 2022 | - | $11.88M(-77.2%) | $111.56M(-7.1%) |
| Mar 2022 | - | $52.01M(+88.2%) | $120.06M(+52.4%) |
| Dec 2021 | $78.80M(+44.4%) | $27.64M(+38.0%) | $78.80M(+52.4%) |
| Sep 2021 | - | $20.02M(-1.7%) | $51.69M(+16.4%) |
| Jun 2021 | - | $20.38M(+89.5%) | $44.41M(-8.3%) |
| Mar 2021 | - | $10.75M(+1902.6%) | $48.42M(-11.3%) |
| Dec 2020 | $54.59M(-286.1%) | $537.00K(-95.8%) | $54.59M(+16.9%) |
| Sep 2020 | - | $12.74M(-47.7%) | $46.71M(+68.2%) |
| Jun 2020 | - | $24.38M(+44.1%) | $27.77M(-148.1%) |
| Mar 2020 | - | $16.92M(-330.6%) | -$57.67M(+96.6%) |
| Dec 2019 | -$29.34M(-115.1%) | -$7.34M(+18.4%) | -$29.34M(-377.4%) |
| Sep 2019 | - | -$6.20M(-89.9%) | $10.57M(-75.9%) |
| Jun 2019 | - | -$61.06M(-234.9%) | $43.85M(-75.4%) |
| Mar 2019 | - | $45.26M(+38.9%) | $178.56M(-8.0%) |
| Dec 2018 | $194.06M(+119.1%) | $32.57M(+20.3%) | $194.06M(+0.7%) |
| Sep 2018 | - | $27.08M(-63.2%) | $192.80M(-0.3%) |
| Jun 2018 | - | $73.64M(+21.2%) | $193.37M(+48.6%) |
| Mar 2018 | - | $60.76M(+94.1%) | $130.11M(+46.9%) |
| Dec 2017 | $88.57M(+45.8%) | $31.31M(+13.2%) | $88.57M(+16.6%) |
| Sep 2017 | - | $27.65M(+166.2%) | $75.98M(+13.7%) |
| Jun 2017 | - | $10.39M(-46.0%) | $66.86M(+0.0%) |
| Mar 2017 | - | $19.22M(+2.7%) | $66.84M(+10.1%) |
| Dec 2016 | $60.73M(+45.5%) | $18.73M(+1.1%) | $60.73M(+9.1%) |
| Sep 2016 | - | $18.52M(+78.6%) | $55.67M(+17.0%) |
| Jun 2016 | - | $10.37M(-20.9%) | $47.59M(+0.7%) |
| Mar 2016 | - | $13.11M(-4.0%) | $47.26M(+13.3%) |
| Dec 2015 | $41.73M(+102.9%) | $13.66M(+30.9%) | $41.73M(+8.9%) |
| Sep 2015 | - | $10.44M(+3.9%) | $38.31M(+21.2%) |
| Jun 2015 | - | $10.05M(+32.6%) | $31.61M(+23.6%) |
| Mar 2015 | - | $7.58M(-26.0%) | $25.57M(+24.3%) |
| Dec 2014 | $20.57M(-0.6%) | $10.25M(+174.3%) | $20.57M(-8.0%) |
| Sep 2014 | - | $3.73M(-6.8%) | $22.35M(+22.4%) |
| Jun 2014 | - | $4.01M(+55.5%) | $18.26M(-13.8%) |
| Mar 2014 | - | $2.58M(-78.6%) | $21.19M(+2.4%) |
| Dec 2013 | $20.69M(>+9900.0%) | $12.03M(-3452.1%) | $20.69M(+91.1%) |
| Sep 2013 | - | -$359.00K(-105.2%) | $10.83M(+5.4%) |
| Jun 2013 | - | $6.94M(+233.8%) | $10.28M(+294.1%) |
| Mar 2013 | - | $2.08M(-4.3%) | $2.61M(+1519.9%) |
| Dec 2012 | $161.00K(-113.7%) | $2.17M(-338.7%) | $161.00K(-96.8%) |
| Sep 2012 | - | -$910.00K(+24.3%) | $5.01M(+3.0%) |
| Jun 2012 | - | -$732.00K(+98.4%) | $4.86M(-298.2%) |
| Mar 2012 | - | -$369.00K(-105.3%) | -$2.45M(+109.2%) |
| Dec 2011 | -$1.17M(-95.7%) | $7.02M(-765.1%) | -$1.17M(-87.6%) |
| Sep 2011 | - | -$1.05M(-86.9%) | -$9.49M(-41.1%) |
| Jun 2011 | - | -$8.04M(-983.1%) | -$16.11M(+56.7%) |
| Mar 2011 | - | $911.00K(-170.1%) | -$10.28M(-62.0%) |
| Dec 2010 | -$27.07M(-19.9%) | -$1.30M(-83.1%) | -$27.07M(+0.0%) |
| Sep 2010 | - | -$7.67M(+246.1%) | -$27.06M(-11.9%) |
| Jun 2010 | - | -$2.22M(-86.0%) | -$30.72M(+20.2%) |
| Mar 2010 | - | -$15.88M(+1131.7%) | -$25.56M(-24.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2009 | -$33.80M(+63.9%) | -$1.29M(-88.6%) | -$33.80M(+28.4%) |
| Sep 2009 | - | -$11.34M(-484.4%) | -$26.32M(-7.4%) |
| Jun 2009 | - | $2.95M(-112.2%) | -$28.43M(-19.6%) |
| Mar 2009 | - | -$24.12M(-489.5%) | -$35.35M(+71.4%) |
| Dec 2008 | -$20.63M(-78.9%) | $6.19M(-146.1%) | -$20.63M(-42.1%) |
| Sep 2008 | - | -$13.45M(+238.7%) | -$35.60M(-2.2%) |
| Jun 2008 | - | -$3.97M(-57.8%) | -$36.39M(-41.1%) |
| Mar 2008 | - | -$9.40M(+7.0%) | -$61.78M(-36.8%) |
| Dec 2007 | -$97.73M(-29.4%) | -$8.79M(-38.3%) | -$97.73M(-43.5%) |
| Sep 2007 | - | -$14.23M(-51.5%) | -$173.01M(-7.4%) |
| Jun 2007 | - | -$29.36M(-35.3%) | -$186.80M(+14.0%) |
| Mar 2007 | - | -$45.35M(-46.1%) | -$163.89M(+18.3%) |
| Dec 2006 | -$138.52M(-1756.0%) | -$84.07M(+200.0%) | -$138.52M(+226.9%) |
| Sep 2006 | - | -$28.02M(+334.6%) | -$42.38M(+460.3%) |
| Jun 2006 | - | -$6.45M(-67.7%) | -$7.56M(-16.2%) |
| Mar 2006 | - | -$19.98M(-265.5%) | -$9.02M(-207.9%) |
| Dec 2005 | $8.37M(+45.4%) | $12.07M(+77.7%) | $8.37M(-67.2%) |
| Sep 2005 | - | $6.79M(-186.0%) | $25.46M(+118.9%) |
| Jun 2005 | - | -$7.91M(+204.4%) | $11.63M(+47.4%) |
| Mar 2005 | - | -$2.60M(-108.9%) | $7.89M(+37.1%) |
| Dec 2004 | $5.75M(+1738.3%) | $29.17M(-514.4%) | $5.75M(-140.5%) |
| Sep 2004 | - | -$7.04M(-39.6%) | -$14.20M(+45.3%) |
| Jun 2004 | - | -$11.65M(+146.1%) | -$9.78M(-283.5%) |
| Mar 2004 | - | -$4.73M(-151.4%) | $5.33M(+1601.9%) |
| Dec 2003 | $313.00K(-101.2%) | $9.21M(-452.9%) | $313.00K(-101.5%) |
| Sep 2003 | - | -$2.61M(-175.5%) | -$20.24M(-4.3%) |
| Jun 2003 | - | $3.46M(-135.5%) | -$21.16M(-42.0%) |
| Mar 2003 | - | -$9.75M(-14.0%) | -$36.50M(+35.7%) |
| Dec 2002 | -$26.89M(+35.1%) | -$11.34M(+221.6%) | -$26.89M(+41.4%) |
| Sep 2002 | - | -$3.53M(-70.3%) | -$19.02M(-15.3%) |
| Jun 2002 | - | -$11.88M(+8327.7%) | -$22.45M(+225.1%) |
| Mar 2002 | - | -$141.00K(-95.9%) | -$6.91M(-65.3%) |
| Dec 2001 | -$19.91M(-56.0%) | -$3.47M(-50.1%) | -$19.91M(-20.0%) |
| Sep 2001 | - | -$6.96M(-289.9%) | -$24.89M(-22.4%) |
| Jun 2001 | - | $3.66M(-127.9%) | -$32.07M(-27.9%) |
| Mar 2001 | - | -$13.14M(+55.5%) | -$44.49M(-1.6%) |
| Dec 2000 | -$45.22M(-24.3%) | -$8.45M(-40.3%) | -$45.22M(-2.1%) |
| Sep 2000 | - | -$14.14M(+61.5%) | -$46.16M(-0.3%) |
| Jun 2000 | - | -$8.76M(-36.8%) | -$46.32M(-10.2%) |
| Mar 2000 | - | -$13.86M(+47.5%) | -$51.56M(-13.6%) |
| Dec 1999 | -$59.70M(-10.4%) | -$9.40M(-34.3%) | -$59.70M(-10.6%) |
| Sep 1999 | - | -$14.30M(+2.1%) | -$66.80M(-5.6%) |
| Jun 1999 | - | -$14.00M(-36.4%) | -$70.80M(+3.4%) |
| Mar 1999 | - | -$22.00M(+33.3%) | -$68.50M(+2.9%) |
| Dec 1998 | -$66.60M(+397.0%) | -$16.50M(-9.8%) | -$66.60M(+79.5%) |
| Sep 1998 | - | -$18.30M(+56.4%) | -$37.10M(+27.9%) |
| Jun 1998 | - | -$11.70M(-41.8%) | -$29.00M(+14.6%) |
| Mar 1998 | - | -$20.10M(-254.6%) | -$25.30M(+88.8%) |
| Dec 1997 | -$13.40M(-59.8%) | $13.00M(-227.5%) | -$13.40M(-59.0%) |
| Sep 1997 | - | -$10.20M(+27.5%) | -$32.70M(+0.6%) |
| Jun 1997 | - | -$8.00M(-2.4%) | -$32.50M(-2.4%) |
| Mar 1997 | - | -$8.20M(+30.2%) | -$33.30M(0.0%) |
| Dec 1996 | -$33.30M(-12.1%) | -$6.30M(-37.0%) | -$33.30M(+23.3%) |
| Sep 1996 | - | -$10.00M(+13.6%) | -$27.00M(+58.8%) |
| Jun 1996 | - | -$8.80M(+7.3%) | -$17.00M(+107.3%) |
| Mar 1996 | - | -$8.20M(+182.8%) | -$8.20M(-43.1%) |
| Dec 1995 | -$37.90M(+165.0%) | - | - |
| Mar 1995 | - | -$2.90M(-31.0%) | -$14.40M(+0.7%) |
| Dec 1994 | -$14.30M | -$4.20M(+40.0%) | -$14.30M(+41.6%) |
| Sep 1994 | - | -$3.00M(-30.2%) | -$10.10M(+42.3%) |
| Jun 1994 | - | -$4.30M(+53.6%) | -$7.10M(+153.6%) |
| Mar 1994 | - | -$2.80M | -$2.80M |
FAQ
- What is Ligand Pharmaceuticals Incorporated annual cash flow from operations?
- What is the all time high annual CFO for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated annual CFO year-on-year change?
- What is Ligand Pharmaceuticals Incorporated quarterly cash flow from operations?
- What is the all time high quarterly CFO for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated quarterly CFO year-on-year change?
- What is Ligand Pharmaceuticals Incorporated TTM cash flow from operations?
- What is the all time high TTM CFO for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated TTM CFO year-on-year change?
What is Ligand Pharmaceuticals Incorporated annual cash flow from operations?
The current annual CFO of LGND is $97.05M
What is the all time high annual CFO for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high annual cash flow from operations is $194.06M
What is Ligand Pharmaceuticals Incorporated annual CFO year-on-year change?
Over the past year, LGND annual cash flow from operations has changed by +$47.47M (+95.75%)
What is Ligand Pharmaceuticals Incorporated quarterly cash flow from operations?
The current quarterly CFO of LGND is -$25.45M
What is the all time high quarterly CFO for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high quarterly cash flow from operations is $73.64M
What is Ligand Pharmaceuticals Incorporated quarterly CFO year-on-year change?
Over the past year, LGND quarterly cash flow from operations has changed by -$44.18M (-235.84%)
What is Ligand Pharmaceuticals Incorporated TTM cash flow from operations?
The current TTM CFO of LGND is $52.87M
What is the all time high TTM CFO for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high TTM cash flow from operations is $194.06M
What is Ligand Pharmaceuticals Incorporated TTM CFO year-on-year change?
Over the past year, LGND TTM cash flow from operations has changed by +$18.51M (+53.87%)